Immunogenicity and Safety of Heterologous and Homologous Boosting With ChAdOx1-S and CoronaVac or a Formulation of SCB-2019 (COVID-19)
Clinical trial NCT05087368 · UNKNOWN
Trial details
- NCT number
- NCT05087368
- Sponsor
- D'Or Institute for Research and Education
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2022-04-01
- Enrollment
- 520
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.